Tamoxifen therapy in unresectable adenocarcinoma of the pancreas.
Twenty-four patients with biopsy-documented unresectable ductal adenocarcinoma of the pancreas were treated with tamoxifen. Six of 15 postmenopausal female patients had documented prolonged survival, with three living greater than 2 years.
D000230:Adenocarcinoma / Q000188:drug therapy* / Q000401:mortality; D000368:Aged; D002285:Carcinoma, Intraductal, Noninfiltrating / Q000188:drug therapy; D005260:Female; D006801:Humans; D008113:Liver Neoplasms / Q000556:secondary; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D010190:Pancreatic Neoplasms / Q000188:drug therapy* / Q000401:mortality; D010865:Pilot Projects; D013629:Tamoxifen / Q000627:therapeutic use*
D013629:Tamoxifen